Trials / Not Yet Recruiting
Not Yet RecruitingNCT06762119
A Study of CAR-T Cells in Subjects with Autoimmune Diseases
A Study to Evaluate the Safety and Efficacy of CAR-T Cells in Subjects with Autoimmune Diseases
- Status
- Not Yet Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with autoimmune diseases.
Detailed description
This study is a single center, one-arm, open label study aimed at evaluate the safety and efficacy of CAR-T Cells to treating Subjects with Autoimmune Diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CAR-T cell | CAR-T cell |
Timeline
- Start date
- 2025-01-10
- Primary completion
- 2027-08-05
- Completion
- 2027-11-15
- First posted
- 2025-01-07
- Last updated
- 2025-01-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06762119. Inclusion in this directory is not an endorsement.